Ignite Creation Date:
2025-12-25 @ 4:27 AM
Ignite Modification Date:
2025-12-26 @ 3:30 AM
Study NCT ID:
NCT06239220
Status:
RECRUITING
Last Update Posted:
2025-08-27
First Post:
2024-01-25
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
PD-L1 t-haNK, N-803 IL-15sa and Cetuximab for Recurrent, Metastatic HNSCC
Sponsor:
Glenn J. Hanna
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-02-16
Start Date Type:
ACTUAL
Primary Completion Date:
2026-07-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-01-31
Completion Date Type:
ESTIMATED
First Submit Date:
2024-01-25
First Submit QC Date:
None
Study First Post Date:
2024-02-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-26
Last Update Post Date:
2025-08-27
Last Update Post Date Type:
ESTIMATED